Oscar Health, Inc. (OSCR) Revenue Growth
Oscar Health, Inc. (OSCR) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 124.37% |
| 2023-12-31 | 42.11% |
| 2024-12-31 | 56.54% |
| 2025-12-31 | 27.50% |
How OSCR compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| KURA | Kura Oncology Inc. | 25.24% |
| MNKD | MannKind Corporation | 22.23% |
| NBIX | Neurocrine Biosciences Inc. | 21.45% |
| INCY | Incyte Corporation | 21.22% |
| RARE | Ultragenyx Pharmaceutical Inc. | 20.18% |
These are five companies in the same sector as OSCR with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Oscar Health, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("OSCR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | OSCR | $32.25 | +0.03% | 3.69M |
| 3 | ||||
| 4 | ||||
| 5 |